IL146467A0 - Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma - Google Patents

Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma

Info

Publication number
IL146467A0
IL146467A0 IL14646700A IL14646700A IL146467A0 IL 146467 A0 IL146467 A0 IL 146467A0 IL 14646700 A IL14646700 A IL 14646700A IL 14646700 A IL14646700 A IL 14646700A IL 146467 A0 IL146467 A0 IL 146467A0
Authority
IL
Israel
Prior art keywords
gliobastoma
treating
release
anticancer agent
biodegradable microspheres
Prior art date
Application number
IL14646700A
Other languages
English (en)
Original Assignee
Prod Ethiques Ethypharm Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prod Ethiques Ethypharm Sa Lab filed Critical Prod Ethiques Ethypharm Sa Lab
Publication of IL146467A0 publication Critical patent/IL146467A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14646700A 1999-05-17 2000-05-17 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma IL146467A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906207A FR2793684B1 (fr) 1999-05-17 1999-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
PCT/FR2000/001315 WO2000069413A1 (fr) 1999-05-17 2000-05-17 Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome

Publications (1)

Publication Number Publication Date
IL146467A0 true IL146467A0 (en) 2002-07-25

Family

ID=9545636

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14646700A IL146467A0 (en) 1999-05-17 2000-05-17 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
IL146467A IL146467A (en) 1999-05-17 2001-11-13 Use of biodegradable microspheres that release anticancer agents to treat glioblastoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146467A IL146467A (en) 1999-05-17 2001-11-13 Use of biodegradable microspheres that release anticancer agents to treat glioblastoma

Country Status (30)

Country Link
US (2) US6803052B2 (xx)
EP (2) EP1053746B1 (xx)
JP (1) JP5230045B2 (xx)
KR (1) KR100649948B1 (xx)
CN (1) CN1210020C (xx)
AR (1) AR024008A1 (xx)
AT (1) ATE228353T1 (xx)
AU (1) AU775320B2 (xx)
BG (1) BG64936B1 (xx)
BR (1) BR0010648A (xx)
CA (1) CA2388656C (xx)
CZ (1) CZ20014137A3 (xx)
DE (1) DE60000842T2 (xx)
DK (1) DK1053746T3 (xx)
EA (1) EA004943B1 (xx)
ES (1) ES2185544T3 (xx)
FR (1) FR2793684B1 (xx)
HK (1) HK1047044B (xx)
HU (1) HUP0201224A3 (xx)
IL (2) IL146467A0 (xx)
MX (1) MXPA01011919A (xx)
NO (1) NO331686B1 (xx)
NZ (1) NZ515515A (xx)
PL (1) PL201614B1 (xx)
PT (1) PT1053746E (xx)
SI (1) SI1053746T1 (xx)
SK (1) SK16342001A3 (xx)
TW (1) TWI229608B (xx)
WO (1) WO2000069413A1 (xx)
ZA (1) ZA200109415B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20022730U1 (de) 1999-08-05 2002-11-21 MAP Medizin-Technologie GmbH, 82152 Planegg Vorrichtung zur Zufuhr eines Atemgases, Befeuchtungsvorrichtung, Atemgasschlauch und Anschlussvorrichtung hierfür
AUPR098300A0 (en) 2000-10-25 2000-11-16 Sirtex Medical Limited Polymer based radionuclide containing microspheres
JP2002154963A (ja) * 2000-11-14 2002-05-28 Yakult Honsha Co Ltd 徐放性抗腫瘍剤
US20020081339A1 (en) * 2000-12-22 2002-06-27 Philippe Menei Treatment of inoperable tumors by stereotactic injection of microspheres
US20040146561A1 (en) * 2001-05-23 2004-07-29 Naoki Sakurai Compositions for promoting healing of bone fracture
EP1389467B1 (en) 2001-05-23 2013-07-03 Mitsubishi Tanabe Pharma Corporation Therapeutic composition for the regenerative treatment of cartilage diseases
WO2003007782A2 (en) 2001-06-29 2003-01-30 Medgraft Microtech, Inc. Biodegradable injectable implants and related methods of manufacture and use
UA77999C2 (en) * 2001-12-10 2007-02-15 Thymosin-alpha 1 for treatment of malignant glioblastoma
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
NZ596207A (en) 2003-06-20 2013-05-31 Resmed Ltd Blower with one of lid and chassis made of metal and plastic composite
WO2005023293A1 (en) * 2003-09-09 2005-03-17 Pohang University Of Science And Technology Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
EP1732594A4 (en) * 2004-03-18 2007-10-17 St Lukes Hospital METHOD FOR THE ADMINISTRATION OF AGENTS WITH DELAYED RELEASE
EP1763321A4 (en) 2004-04-16 2010-02-17 Critical Care Innovations Inc SYSTEMS AND METHOD FOR ENHANCING ABLATION OF IMAGE-GUIDED FABRIC
US8088413B2 (en) * 2004-04-16 2012-01-03 Nuvue Therapeutics, Inc. Methods for improved cryo-chemotherapy tissue ablation
EP3085361A1 (en) 2004-09-07 2016-10-26 Biocompatibles UK Limited Compositions comprising camptothecins in microspheres
US8702580B2 (en) * 2004-10-06 2014-04-22 Brainlab Ag Method and device for assisting in a tissue treatment
CN100386115C (zh) * 2004-10-14 2008-05-07 孔庆忠 一种抗癌药物组合物
CN1299685C (zh) * 2005-01-26 2007-02-14 上海大学 氟尿嘧啶载药微球及其制备方法
CN100340297C (zh) * 2005-02-03 2007-10-03 山东蓝金生物工程有限公司 抗癌体内植入剂
CN1923282B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含激素类药物的抗癌缓释注射剂
CN100464785C (zh) * 2005-08-30 2009-03-04 孔庆忠 一种抗癌药物缓释注射剂及其应用
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂
CN1923173B (zh) * 2006-02-24 2010-05-19 济南康泉医药科技有限公司 一种同载抗癌抗生素及其增效剂的抗癌药物缓释剂
WO2007105218A2 (en) * 2006-03-14 2007-09-20 Yeda Research And Development Co. Ltd. Composition and method for brain tumor therapy
CN100464736C (zh) * 2006-03-17 2009-03-04 山东蓝金生物工程有限公司 同载抗代谢药物及其增效剂的抗癌缓释注射剂
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
SG11201403062YA (en) 2011-12-13 2014-07-30 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
US10342769B2 (en) 2014-11-14 2019-07-09 Navinta Iii Inc Carmustine pharmaceutical composition
EP3373907A4 (en) * 2015-11-11 2019-12-18 Qrono, Inc. EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
NZ260909A (en) * 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
DE69727491T2 (de) * 1996-10-16 2004-12-02 Regeneron Pharmaceuticals, Inc. Verfahren zur verabreichung von wachstumsfaktoren
EP0911334B1 (en) * 1997-03-31 2008-05-21 Toray Industries, Inc. Quinolinomorphinane derivatives and medicinal use thereof
AU745324B2 (en) * 1997-10-14 2002-03-21 Cenes Pharmaceuticals, Inc. Therapeutic methods comprising use of a neuregulin

Also Published As

Publication number Publication date
ZA200109415B (en) 2003-01-29
DE60000842T2 (de) 2003-08-28
AU775320B2 (en) 2004-07-29
SI1053746T1 (en) 2003-04-30
EP1053746B1 (fr) 2002-11-27
EA200101206A1 (ru) 2002-04-25
HK1047044B (zh) 2005-12-23
PL201614B1 (pl) 2009-04-30
BG106106A (en) 2002-05-31
CN1210020C (zh) 2005-07-13
KR20020000178A (ko) 2002-01-04
HK1047044A1 (en) 2003-02-07
NO20015501L (no) 2002-01-09
NZ515515A (en) 2004-02-27
ES2185544T3 (es) 2003-05-01
WO2000069413A1 (fr) 2000-11-23
ATE228353T1 (de) 2002-12-15
KR100649948B1 (ko) 2006-11-24
EA004943B1 (ru) 2004-10-28
AU4764100A (en) 2000-12-05
CA2388656A1 (fr) 2000-11-23
HUP0201224A2 (hu) 2002-11-28
US7041241B2 (en) 2006-05-09
US20030175356A1 (en) 2003-09-18
BR0010648A (pt) 2002-02-19
CN1356892A (zh) 2002-07-03
NO20015501D0 (no) 2001-11-09
FR2793684B1 (fr) 2001-08-10
CA2388656C (fr) 2011-04-26
HUP0201224A3 (en) 2004-05-28
FR2793684A1 (fr) 2000-11-24
NO331686B1 (no) 2012-02-20
DE60000842D1 (de) 2003-01-09
TWI229608B (en) 2005-03-21
AR024008A1 (es) 2002-09-04
BG64936B1 (bg) 2006-10-31
PT1053746E (pt) 2003-04-30
CZ20014137A3 (cs) 2002-06-12
EP1228755A1 (fr) 2002-08-07
IL146467A (en) 2006-06-11
SK16342001A3 (sk) 2002-08-06
JP5230045B2 (ja) 2013-07-10
JP2002544219A (ja) 2002-12-24
EP1053746A1 (fr) 2000-11-22
US6803052B2 (en) 2004-10-12
US20020051749A1 (en) 2002-05-02
MXPA01011919A (es) 2002-05-06
DK1053746T3 (da) 2003-03-31
PL352372A1 (en) 2003-08-25

Similar Documents

Publication Publication Date Title
IL146467A0 (en) Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
EP1205459A4 (en) GAS-CREATING COMPOSITION FOR BELTS
HK1049164A1 (zh) 吲衍生物和其在治療骨質疏鬆中的應用以及其它應用
EP1189597A4 (en) COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
PL352931A1 (en) Compositions and uses of et743 for treating cancer
GB0216124D0 (en) Encapsulated time release additive for absorbent articles
EP1225971A4 (en) CONTROLLED RELEASE OF SUBSTANCES
HK1051142A1 (en) Formulation of substituted benzimidazoles
AU6510400A (en) Slow release microspheres
HUP0103807A3 (en) Device for dispersal of fluidized powder
IL144603A0 (en) Controlled release formulation for treating copd
SG92610A1 (en) The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
GB2356831B (en) Release agent delivery system and method for printer devices
EP1189610A4 (en) METHOD AND MARKERS FOR PROGNOSING THE EFFECTIVENESS OF CANCER AGENTS
GB9904485D0 (en) Method for protecting and/or controlled release of active ingredient
EP1086921A4 (en) LIFT SAFETY DEVICE
GB2322867B (en) Release agent
GB9911546D0 (en) Release of poorly soluble agents
GB0124327D0 (en) Spring loaded hydraulic release brake
AU5305500A (en) Modified biodegradable polyester microspheres for stabilizing and improving the release profile of drugs encapsulated within the microspheres
EP1218025A4 (en) USE OF MULLER CHANNEL INHIBITION SUBSTANCE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS CHARACTERIZED BY EXCESS ANDROGENES
GB9921062D0 (en) Use of cholestrol-lowering agent
GB9908962D0 (en) Calcified microspheres
TW449230U (en) Improved through-hole pad of PCB
EP1210077A4 (en) COMPOSITION AND SYSTEMS FOR THE TREATMENT OF HYPERPIGMENTATION

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed